The 6000 patients are from different drug trials to prove the ALP 15% reduction is meaningful clinical benefits, where do yo see the 6000 patients are from OCA trials?
"In order to evaluate the clinical relevance of the POISE primary endpoint, Intercept sponsored an independent study conducted by the Global PBC Study Group (the 'PBC Supergroup'), consisting of 15 leading PBC centers in eight countries that contributed to a clinical outcomes database of more than 6,000 PBC patients."
Market Data 
Markets 
AI
